Peter Bryson

Optimal Chemotherapy Treatment for Women with Recurrent Ovarian Cancer

Michael Fung‐Kee‐Fung, Thomas R. Oliver, Laurie Elit et al. · Current Oncology · 2007 · 226 citations · Full text

Medicine, Gynecology, Oncology +14

Randomized phase II study of two schedules of topotecan in previously treated patients with ovarian cancer: a National Cancer Institute of Canada Clinical Trials Group study.

Paul Hoskins, Elizabeth A. Eisenhauer, Sandra Beare et al. · Journal of Clinical Oncology · 1998 · 172 citations

Medicine, Oncology, Pharmacology +17

Concurrent radiation and chemotherapy in vulvar carcinoma

Gillian Thomas, A.J. Dembo, A.D. DePetrillo et al. · Gynecologic Oncology · 1989 · 168 citations

Medicine, Oncology, Radiation Oncology +14

Identification of the IGF1/PI3K/NF κB/ERK gene signalling networks associated with chemotherapy resistance and treatment response in high-grade serous epithelial ovarian cancer

Madhuri Koti, R. J. Gooding, Paulo Nuin et al. · BMC Cancer · 2013 · 113 citations · Full text

Medicine, Oncology, Pharmacology +17

Initial Evaluation and Referral Guidelines for Management of Pelvic/Ovarian Masses

Tien Le, Christopher Giede, Shia Salem et al. · Journal of Obstetrics and Gynaecology Canada · 2009 · 56 citations

Medicine, Gynecology, Oncology +16